Health Dictionary Find a Doctor

Post-streptococcal glomerulonephritis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Effective measures for the primary prevention of post-streptococcal glomerulonephritis include improving hand hygiene, better housing, prevent overcrowding, treatment of an infected patient within 24 hours with antibiotics and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.

Primary Prevention

  • Effective measures for the primary prevention of post-streptococcal glomerulonephritis include:

References

  1. “Group A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC”.
  2. Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P (1999). “Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis”. Pediatr Infect Dis J. 18 (4): 327–32. PMID 10223684.
  3. Rodríguez-Iturbe B, Rubio L, García R (1981). “Attack rate of poststreptococcal nephritis in families. A prospective study”. Lancet. 1 (8217): 401–3. PMID 6110037.
  4. Rodriguez-Iturbe B, Musser JM (2008). “The current state of poststreptococcal glomerulonephritis”. J Am Soc Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.
  5. Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (July 2005). “Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes”. Clin. Diagn. Lab. Immunol. 12 (7): 833–6. doi:10.1128/CDLI.12.7.833-836.2005. PMC 1182208. PMID 16002631.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH